New Antimicrobial Agents … but No Susceptibility Tests!
Clin Infect Dis
.
2016 Dec 1;63(11):1530-1531.
doi: 10.1093/cid/ciw603.
Epub 2016 Aug 31.
Authors
Jane E Ambler
1
,
Kevin M Krause
2
,
Judith N Steenbergen
3
,
Nicole E Scangarella-Oman
4
,
Linda A Miller
4
,
Sachin S Bhagwat
5
,
Alisa W Serio
2
,
Laurent Chesnel
6
,
Nicole M Mahoney
6
,
Mary R Motyl
6
,
Ian A Critchley
7
,
Joseph P Iaconis
8
,
Gregory G Stone
8
,
Jeff Alder
9
,
Luigi Xerri
10
,
Sandra P McCurdy
11
,
David F van Veenhuyzen
12
,
Trudy Grossman
13
,
Roger M Echols
14
,
Gregory Williams
15
,
Patricia A Bradford
16
Affiliations
1
Wockhardt/Morton Grove Pharmaceuticals, Inc, Morton Grove, Illinois.
2
Achaogen, Inc, South San Francisco, California.
3
Paratek Pharmaceuticals, King of Prussia.
4
GlaxoSmithKline, Collegeville, Pennsylvania.
5
Discovery Research, Wockhardt Research Centre, Aurangabad, India.
6
Merck Sharp & Dohme Corp, Kenilworth, New Jersey.
7
Allergan, Irvine, California.
8
Antibiotics Business Unit, AstraZeneca Pharmaceuticals, Waltham, Massachusetts.
9
Global Clinical Development, General Medicine Bayer HealthCare, Parsippany, New Jersey.
10
VenatoRx Pharmaceuticals, Inc, Malvern, Pennsylvania.
11
Melinta Therapeutics, New Haven, Connecticut.
12
Shionogi Inc, Florham Park, New Jersey.
13
Tetraphase Pharmaceuticals, Inc, Watertown, Massachusetts.
14
Infectious Disease Drug Development Consulting, LLC, Easton, Connecticut.
15
GB Williams Consulting, Davis, California.
16
Antimicrobial Development Specialists, LLC, Nyack, New York.
PMID:
27581762
DOI:
10.1093/cid/ciw603
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Bacterial Agents
Anti-Infective Agents*
Microbial Sensitivity Tests*
Substances
Anti-Bacterial Agents
Anti-Infective Agents